Bad Marienberg (www.aktiencheck.de)???? Moderna im Fokus: Piper Sandler senkt Kursziel auf 63 USD - Rating "overweight" bleibt klar bestehenDie US-Investmentbank…
Boston, MA (www.aktiencheck.de) - Moderna-Aktienanalyse der Leerink Partners:Leerink habe nach dem jährlichen Investorentag des Biotech-Unternehmens, bei dem Moderna ein Update…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Wolfe Research:Wolfe Research habe das Kursziel für die Aktie von Moderna (ISIN: US60770K1079, WKN:…
Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up…
HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Biontech mit einem Kursziel von 150 US-Dollar auf "Buy"…
Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse der Bank of America (BofA):BofA Securities habe das Kursziel für die Aktie von Moderna Inc. (ISIN:…
Key PointsInitiated stake: 500,000 shares, an estimated $12.91 million increasePost-trade Moderna position: 500,000 shares, valued at $12.91 millionModerna now accounts…
Dow, S&P 500, and Nasdaq futures are rising in premarket trading as the stock market digests the latest labor market…
Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during…
MRNA posts narrower-than-expected Q3 loss and lifts liquidity outlook for 2025, as cost cuts and revised spending plans boost investor…
…
Moderna ist ein US-Biotechnologieunternehmen mit Sitz in Cambridge, Massachusetts, das auf die Entwicklung von Medikamenten auf Basis der mRNA-Technologie spezialisiert…
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 6.9% in the afternoon session after ongoing concerns about its financial performance and…
…
Moderna stock soars after report of potential buyout talks…
Moderna (MRNA) reached $26.74 at the closing of the latest trading day, reflecting a +1.87% change compared to its last…
Key PointsLancaster Investment Management bought over 620,000 shares in 10x Genomics (TXG) worth around $7.27 million.10x Genomics, a new holding…
New York (www.aktiencheck.de) - Moderna-Aktienanalyse der Citigroup:Citigroup habe das Kursziel für die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9,…
Tesla, IBM and Moderna fall premarket; American Airlines rises…
These are the stocks posting the largest moves in extended trading.…
…
…
Modernas sales have plummeted in recent years along with diminishing demand for COVID vaccines.…
In the closing of the recent trading day, Moderna (MRNA) stood at $27.92, denoting a +2.12% move from the preceding…
Moderna (MRNA) concluded the recent trading session at $28.38, signifying a +2.83% move from its prior days close.…
Moderna plans up to 10 product launches over four years, aiming to cut reliance on fading COVID-19 vaccine sales.…
In the closing of the recent trading day, Moderna (MRNA) stood at $24.61, denoting a -4.91% move from the preceding…
In the most recent trading session, Moderna (MRNA) closed at $25.51, indicating a +2.03% shift from the previous trading day.…
Growth in the Lipid Nanoparticles (LNPs) market is driven by increasing demand for mRNA-based therapeutics and advances in delivery systems.…
Biontech und Moderna erzielten Milliardengewinne mit Impfstoffen. Inzwischen ist das Boomgeschäft eingebrochen – und die Strategien driften auseinander. Während Moderna…
Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended…
Moderna also lost less than Wall Street analysts were expecting for the second quarter and posted revenue that topped estimates.…
…
Earnings call transcript: Moderna Q2 2025 beats forecasts, stock dips…
Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by robust Spring COVID booster…
Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares fell almost 9% in early trade as the pharmaceutical giant lowered its full-year guidance and…
Während der Corona-Pandemie benötigt der Pharmakonzern Moderna viele zusätzliche Angestellte, um mit der Impfstoffentwicklung und -produktion nachzukommen. Jetzt ebbt die…
In a memo to employees, Moderna CEO Stephane Bancel said the company expects to have fewer than 5,000 workers by…
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find themselves on different…
Moderna to cut 10% of global workforce, CEO Bancel says…
Moderna ist ein US-amerikanisches Biotechnologieunternehmen mit Sitz in Cambridge, Massachusetts, das sich auf die Entwicklung von mRNA-basierten Therapien und Impfstoffen…
Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
In the latest trading session, Moderna (MRNA) closed at $34.01, marking a -1.9% move from the previous day.…
In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at…
Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities:
Die Analysten von BofA Securities stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…
In the most recent trading session, Moderna (MRNA) closed at $31.25, indicating a -2.95% shift from the previous trading day.…
Firms like Moderna that are rapidly adopting AI and will have a higher mix of AI software robots to humans…
…
Key PointsThis stock used to be a highflyer but has struggled in recent years as demand waned for its flagship…
The latest trading day saw Moderna (MRNA) settling at $33.64, representing a -1.87% change from its previous close.…